Finance

Beta
Lists
601089:SHA
Beijing Foyou Pharma Co Ltd
CNÂ¥16.52
-3.39%
(-0.58) 1D
Jun 8, 2:56:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 601089...
Open
CNÂ¥17.20
High
CNÂ¥17.20
Low
CNÂ¥16.35
Mkt. cap
8.21B
Avg. vol.
3.24M
Volume
2.97M
Dividend
3.03%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
17.73
52-wk high
CNÂ¥33.50
52-wk low
CNÂ¥16.16
EPS
CNÂ¥0.93
No. of employees
4K
Open
CNÂ¥17.20
High
CNÂ¥17.20
Low
CNÂ¥16.35
Mkt. cap
8.21B
Avg. vol.
3.24M
Volume
2.97M
Dividend
3.03%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jun 2, 2026
P/E ratio
17.73
52-wk high
CNÂ¥33.50
52-wk low
CNÂ¥16.16
EPS
CNÂ¥0.93
No. of employees
4K
News stories
From sources across the web
About Beijing Foyou Pharma Co Ltd
CEO-
Employees3.91K
FoundedFeb 3, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
803.50M
886.63M
983.84M
811.17M
Cost of goods sold
274.62M
306.52M
366.92M
310.71M
Cost of revenue
274.62M
306.52M
366.92M
310.71M
Research and development expenses
91.50M
111.15M
126.58M
97.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
276.22M
343.96M
388.17M
301.77M
Operating expense
377.39M
458.31M
531.85M
399.87M
Total operating expenses
652.01M
764.83M
898.77M
710.59M
Operating income
151.49M
121.81M
85.07M
100.58M
Other non operating income
-532.93K
-4.25M
4.38M
-127.61K
EBT including unusual items
157.20M
116.35M
105.48M
104.06M
EBT excluding unusual items
157.71M
120.24M
98.86M
105.83M
Income tax expense
19.53M
7.03M
12.01M
7.86M
Effective tax rate
12.42%
6.04%
11.38%
7.55%
Other operating expenses
9.59M
2.47M
14.99M
2.01M
Net income
137.23M
107.47M
94.02M
95.41M
Net profit margin
17.08%
12.12%
9.56%
11.76%
Earnings per share
-
-
-
-
Interest and investment income
7.06M
3.13M
9.82M
5.63M
Interest expense
-419.28K
-330.34K
-310.23K
-246.71K
Net interest expenses
6.64M
2.80M
9.51M
5.38M
Depreciation and amortization charges
-
-
-
-
EBITDA
176.42M
142.70M
113.10M
128.61M
Gain or loss from assets sale
35.00K
-35.00K
-21.84K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more